+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

South and Central America Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology Neuromodulation, and Internal Neuromodulation; Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinen

  • ID: 5231389
  • Report
  • November 2020
  • 186 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
According to a new market research study of ‘South & Central America Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Analysis by Product Type, Material, Application, and Distribution Channel’ the South & Central America Neuromodulation market is expected to reach US$ 310.39 million in 2027 from US$ 221.74 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027. The report provides trends prevailing in the South & Central America Neuromodulation market and the factors driving market along with those that act as hindrances.

Based on the technology, the South & Central America Neuromodulation market is segmented into External (Non-Invasive) Neuromodulation and Internal Neuromodulation. The Internal Neuromodulation segment held the largest share of the market in 2019. The growth of the Internal Neuromodulation segment is attributed to the increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology are also estimated to offer lucrative opportunity for the segment growth during the forecast period.

The growth of the market is attributed to the increasing incidence of neurological disorders, rapidly improving healthcare infrastructure, growing government support in the country. However, high Cost of Neuromodulation Devices is likely to restraint the growth of the market during the forecast years.

BOSTON SCIENTIFIC CORPORATION, ABBOTT and MEDTRONIC are among the leading companies operating in the South & Central America Neuromodulation market.

The report segments South & Central America Neuromodulation Market as Follows:

By Technology

External (Non-Invasive) Neuromodulation
  • Respiratory Electrical Stimulation (RES)
  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Transcranial Magnetic Stimulation (TMS)
Internal Neuromodulation
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Gastric Electrical Stimulation (GES)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
By Country
  • UAE
  • Saudi Arabia
  • South Africa
Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America Neuromodulation market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global South & Central America Neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Neuromodulation Market - by Technology
1.3.2 Neuromodulation Market - by Application
1.3.3 Neuromodulation Market - by End User
1.3.4 South & Central America Neuromodulation Market - by Country

2. South & Central America Neuromodulation Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Neuromodulation Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America- PEST Analysis
4.3 Expert Opinion

5. South & Central America Neuromodulation Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Neurological Disorders
5.1.2 Growing Developments in Neuromodulation Technology
5.2 Market Restraints
5.2.1 High Cost of Neuromodulation Devices
5.3 Market Opportunities
5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis

6. Neuromodulation Market - South & Central America Analysis
6.1 Neuromodulation Market Revenue Forecasts and Analysis

7. Neuromodulation Market Analysis - by Technology
7.1 Overview
7.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
7.3 External Neuromodulation
7.3.1 Overview
7.3.2 External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Respiratory Electrical Stimulation (RES)
7.3.3.1 Overview
7.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
7.3.4.1 Overview
7.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Transcranial Magnetic Stimulation (TMS)
7.3.5.1 Overview
7.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Internal Neuromodulation
7.4.1 Overview
7.4.2 Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Deep Brain Stimulation (DBS)
7.4.3.1 Overview
7.4.3.2 Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Sacral Nerve Stimulation (DBS)
7.4.4.1 Overview
7.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Gastric Electric Stimulation (GES)
7.4.5.1 Overview
7.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4.6 Spinal Cord Stimulation (SCS)
7.4.6.1 Overview
7.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4.7 Vagus Nerve Stimulation (VNS)
7.4.7.1 Overview
7.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis - by Application
8.1 Overview
8.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
8.3 Chronic Pain Management
8.3.1 Overview
8.3.2 Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Failed Back Syndrome
8.4.1 Overview
8.4.2 Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Epilepsy
8.5.1 Overview
8.5.2 Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Tremor
8.6.1 Overview
8.6.2 Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Incontinence
8.7.1 Overview
8.7.2 Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.8 Depression
8.8.1 Overview
8.8.2 Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.9 Dystonia
8.9.1 Overview
8.9.2 Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.10 Gastroparesis
8.10.1 Overview
8.10.2 Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.11 Parkinson’s Disease
8.11.1 Overview
8.11.2 Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.12 Obsessive-Compulsive Disorder (OCD)
8.12.1 Overview
8.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.13 Migraine
8.13.1 Overview
8.13.2 Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

9. Neuromodulation Market Analysis - by End User
9.1 Overview
9.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Home Healthcare
9.5.1 Overview
9.5.2 Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

10. Neuromodulation Market - Geographic Analysis
10.1 South & Central America: Neuromodulation Market
10.1.1 Overview
10.1.2 South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
10.1.3 South and Central America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.3.1 South and Central America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.3.2 South and Central America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.4 South and Central America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.5 South and Central America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.6 South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
10.1.7 Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Brazil: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.7.2.1 Brazil: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8 Brazil: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Brazil: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Brazil: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.1.9 Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Argentina: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.1 Argentina: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.2.2 Argentina: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Argentina: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Argentina: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on South & Central America Neuromodulation Market
11.1 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Neuromodulation Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 NeuroPace, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 NeuroSigma, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 NEVRO CORP.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Synapse Biomedical Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Soterix Medical Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Integer Holdings Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Magstim
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 Glossary of Terms

List of Tables
Table 1. South and Central America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 2. South and Central America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. South and Central America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. South and Central America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 7. Brazil: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. Brazil: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. Brazil: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. Brazil: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Argentina: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Argentina: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Argentina: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Argentina: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Argentina: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. Organic Developments Done by Companies
Table 17. Inorganic Developments Done by Companies
Table 18. Glossary of Terms, Neuromodulation Market

List of Figures
Figure 1. South & Central America Neuromodulation Market Segmentation
Figure 2. South & Central America Neuromodulation Market, by Country
Figure 3. South & Central America Neuromodulation Market Overview
Figure 4. Internal Neuromodulation Segment Held Largest Share of Technology Segment in South & Central America Neuromodulation Market
Figure 5. Brazil is Expected to show Remarkable Growth during the Forecast Period
Figure 6. South & Central America Neuromodulation Market - Leading Country Markets (US$ Mn)
Figure 7. South & Central America PEST Analysis
Figure 8. Neuromodulation Market Impact Analysis of Drivers and Restraint
Figure 9. South & Central America Neuromodulation Market - Revenue Forecasts and Analysis-2019-2027
Figure 10. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
Figure 11. External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Gastric Electric Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
Figure 22. Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
Figure 34. Hospitals Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 37. South and Central America: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
Figure 38. South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 39. South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 40. Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc.
  • Integer Holdings Corporation
  • Magstim
Note: Product cover images may vary from those shown
Adroll
adroll